United States – March 29, 2022 —
Menopause Treatment Market Overview
The Global menopause treatment market size is expected to reach USD 15.64 billion at a CAGR of 6.18% 2027, says Market Research Future (MRFR). Menopausal hormone therapy is also known as hormone replacement therapy or postmenopausal therapy. It is considered to help relieve symptoms of menopause. However, there may be adverse effects such as vaginal bleeding, hip and vertebral fractures, dementia, urinary incontinence, breast cancer, heart attack, blood clots, stroke and colorectal cancer.
The awareness related to adverse effects and risks associated with menopausal hormone therapy might increase the adoption of the supplement by menopausal women. The pandemic has negatively impacted people’s health. The amount of pressure, stress and mental health problems are high nowadays, and it results in hormonal imbalance. The pandemic and lockdown restrictions led to growing awareness about health and the role that products such as dietary supplements food supplements play a vital role in promoting health, including menopausal symptoms.
Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/4579
Menopause Treatment Market segmentation
Menopause treatment market is segmented into hormonal and non-hormonal treatment. Hormonal treatment further segmented into Estrogen, progesterone, and a mixture of the two are the three types of hormonal treatment. Non-hormonal includes antidepressants and others. The hormonal treatment segment leads the global industry, as hormone therapy is the most frequently recommended or prescribed drug for menopausal symptoms such as hot flashes and vaginal dryness.
Menopause Treatment Market Regional analysis
Since 2019 the American menopause treatment market has been in the lead, in view of the rapid increase in urogenital complications and vasomotor symptoms among women, new drug launches, and the existence of a well-settled healthcare industry with modern infrastructure. The consistent expansion in the female population aged more than 60, the high commonness of an unhealthy lifestyle, and the rising introduction of novel drugs also work in favor of the American menopause treatment market. In the United States, supportive government initiatives concerned with women’s health and the resultant increase in awareness also rest the regional market’s growth scope.
The Asia Pacific shows the potential to obtain the fastest growth rate over the estimation period on account of the mounting awareness level of the rising instances of players and about women’s health entering joint ventures with the distributors as well as local firms. In this region, women are increasingly turning to technologically literate and digitally sufficient. The rapid increase in the working women population in this region uses smartphones and is well-versed with digitalization related to healthcare, thereby emerging as a potential menopause treatment market.
The top key players of menopause treatment market are Novo Nordisk A/S (Denmark), Pfizer Inc. (US), Allergan (Ireland), Eli Lily and Company (US), Emcure Pharmaceuticals Ltd (India), Novartis AG (Switzerland), Cipla Inc. (India),Teva Pharmaceuticals (Israel), Merck & Co. Inc. (US), Abbott Laboratories (US).
Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/menopause-treatment-market-4579
In 2020 Cipla Inc. acquired a total of four brands from India-based companies Wrenbury, which are Cdense, CPink, Folinine and Productiv, to ease its mark in the women’s health segment, especially in menopause treatment.
stellas Pharma is one step closer to bringing nonhormonal menopause therapy to the market. If it is approved by the U.S. food and drug administration, that would be a first-class non-hormonal option.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Name: Market Research Future
Email: Send Email
Organization: Market Research Future (part of Wantstats Research and Media Private Limited)
Release ID: 89072172
If you detect any issues, problems, or errors in this press release content, kindly contact firstname.lastname@example.org to notify us. We will respond and rectify the situation in the next 8 hours.